|
業務類別
|
Medical Devices |
|
業務概覽
|
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patientsreceiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. |
| 公司地址
| 12510 Prosperity Drive, Suite 370, Silver Spring, MD, USA, 20904 |
| 電話號碼
| +1 240 247-1170 |
| 傳真號碼
| +1 408 734-2629 |
| 公司網頁
| https://www.aziyo.com |
| 員工數量
| 51 |
| Mr. Matthew B. Ferguson |
Chief Financial Officer and Principal Accounting Officer |
美元 385.00K |
04/04/2025 |
| Dr. Michelle Leroux Williams, PhD |
Chief Scientific Officer |
美元 355.00K |
04/04/2025 |
| Dr. C. Randal Mills, PhD |
Director, Chief Executive Officer and President |
美元 600.00K |
04/04/2025 |
|
|
| Mr. David Colpman |
Independent Director |
04/04/2025 |
| Mr. Kevin Rakin |
Executive Chairman of the Board |
04/04/2025 |
| Mr. Guido J. Neels |
Director |
14/10/2025 |
| Ms. Brigid A. Makes |
Independent Director |
04/04/2025 |
| Dr. C. Randal Mills, PhD |
Director, Chief Executive Officer and President |
04/04/2025 |
|
|
|
|
